Tag: Cerecor

August 21, 2019

Cerecor Receives Fast Track Designation from FDA for CERC-802

Cerecor (NASDAQ:CERC) has announced that the US Food and Drug Administration has granted the company fast track designation for CERC-802...
February 19, 2019

Cerecor Receives Fast Track Designation from FDA for CERC-801 for the Treatment of PGM1 Deficiency

Cerecor (NASDAQ:CERC) has announced that the US Food and Drug Administration (FDA) has designated fast track designation for CERC-901, an...
February 15, 2019

Cerecor Announces CERC-301 Granted U.S. Patent

Cerecor (NASDAQ: CERC) has announced that the US Patent and Trademark Office issued US Patent No. 10,202,363 on February 12 for...
January 27, 2019

5 Top Weekly NASDAQ Biotech Stocks: Synergy on Top

Synergy Pharmaceuticals, Alpine Immune Sciences, Aerpio Pharmaceuticals, Correvio Pharma and Athersys were last week's top gainers.
January 16, 2019

FDA Grants Cerecor’s Three Substrate Replacement Therapies Orphan Drug Designation

Cerecor (NASDAQ:CERC), a biopharmaceutical company focused on becoming a leader in development and commercialization of therapies for rare and orphan...
September 25, 2018

Cerecor to Acquire Ichorion Therapeutics

Cerecor (NASDAQ:CERC), a biopharmaceutical company focused on becoming a leader in development and commercialization of treatments for orphan disorders, announced...
August 26, 2018

5 Top Weekly NASDAQ Biotech Stocks: Bellerophon Leads the Pack

Bellerophon Therapeutics, Chiasma, BioLife Solutions, Cerecor and MiMedx Group were last week's top gainers on the NASDAQ Biotechnology Index.